PPLPHARMA
NSEF&OPiramal Pharma Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹177.16
5.17 (3.01%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹23.55K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹132.3+33.9%
52W High₹220.85-19.8%
Current Price
₹177.16
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹141.73
Upper Circuit₹212.59
Reference Price
₹177.16
Investment Checklist
Double Top on 1W (BREAKOUT CONFIRMED) — target ₹166.44
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹168.36
Trend: Price above all key MAs — strong uptrend
Golden Cross detected 5 day(s) ago
Volume divergence: Bearish (price up, volume down)
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
45%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
170.22
EMA50
167.32
EMA200
173.51
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows7
Lower Highs5
Lower Lows2
Support & Resistance Levels
Resistance (Above)
₹181.24
₹185.08
₹187.00
₹190.76
₹196.82
Support (Below)
₹175.88
₹170.19
₹165.84
₹160.54
₹158.10
Volume Analysis
TrendDECREASING
Change-44.00%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Recent MA Crossovers
Golden Cross
5 days ago
BUY
Stop Loss Levels
Fixed Risk
1% Risk₹175.39
3% Risk₹171.85
5% Risk₹168.30
7% Risk (Custom)
₹164.76Technical Levels
1x ATR (Volatility)₹170.08
2x ATR (Swing)₹163.00
3x ATR (Trend)₹155.92
Immediate Support₹175.88
Moving Averages
EMA 9 (Short-term)₹172.33
EMA 20 (Medium-term)₹170.22
EMA 50 (Trend)₹167.32
EMA 200 (Long-term)₹173.51
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹2,204.2 Cr | ₹2,663.9 Cr | ₹1,933.7 Cr | ₹2,139.9 Cr |
| Net Profit | ₹3.7 Cr | ₹153.5 Cr | ₹-81.7 Cr | ₹-136.2 Cr |
| EPS | ₹0.03 | — | ₹-0.62 | ₹-1.03 |
| Operating Profit | ₹366.9 Cr | ₹615.6 Cr | ₹204.4 Cr | ₹208.1 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Piramal Pharma Limited | ₹177.16 | +3.01% | — | ₹23.55K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 16 Jul 2025 | Dividend - Re 0.14 Per Share | DIVIDEND |
| 12 Jul 2024 | Dividend - Rs 0.11 Per Share | DIVIDEND |
| 02 Aug 2023 | Rights 5:46 @ Premium Rs 71/- | RIGHTS_ISSUE |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for PPLPHARMA
View All
positive
Business Standard - Markets 1d ago
Piramal Pharma shares rise 4% on successful closure of US FDA inspection
Piramal Pharma said that the US FDA has issued an Establishment Inspection Report (EIR) for its Sellersville facility, and the inspection has now been successfully closed.
PPLPHARMAHealthcare
positive
NDTV Profit 1d ago
Piramal Pharma Share Price Gains Over 3% As US FDA Closes Inspection
With the closing of the inspection, strong buying interest has been witnessed in Piramal Pharma stock
ARSSBLPPLPHARMAFinancial ServicesHealthcare
positive
LiveMint - Markets 5d ago
Stocks to buy or sell: Dharmesh Shah of ICICI Sec suggests buying Shriram Finance, Piramal Pharma shares on 6 July
Indian benchmark indices, Sensex and Nifty 50, opened higher on July 6, driven by gains in private banking stocks following strong quarterly updates from HDFC Bank and Axis Bank. Market breadth was positive with 14 of the 16 major indices in the green.
ABSLBANETFALPL30IETFAONETMMQ50AONETOTALAUBANKAUTOIETFAXISBANKAXISBPSETFBANKADDBANKBEESBANKBETABANKBETFBANKETFBANKIETFBANKINDIABANKNIFTY1BANKPSUBBNPNBETFBNKETFAXISCAPITALSFBCOMMOIETFCONSUMAXISCONSUMIETFEBANKNIFTYEQUITASBNKESAFSFBEVIETFFINIETFFMCGIETFGILT10BETAGILT5BETAGILT5YBEESGROWWPSUBKGSEC10IETFGSEC10YEARGSEC5IETFHDFCBANKHDFCGROWTHHDFCLIQUIDHDFCMID150HDFCNEXT50HDFCNIF100HDFCNIFBANHDFCNIFITHDFCNIFTYHDFCPSUBKHDFCPVTBANHDFCSENSEXHDFCSML250HEALTHAXISHEALTHIETFICICIBANKINDIANBINFRAIETFIOBIRFCITAXISITIETFJSFBLIQUIDSHRILOWVOLIETFLTFLTGILTBEESLTGILTCASEMETALIETFMIDCAPIETFMOCAPITALMOM30IETFMUFINNEXT50IETFNIF100IETFNIFTYAXISNIFTYIETFNPBETOILIETFPHARMABEESPIRAMALFINPPLPHARMAPSUBANKPSUBANKADDPSUBNKBEESPSUBNKIETFPVTBANIETFPVTBANKADDQUAL30IETFSENSEXAXISSENSEXIETFSETFNIFBKSHAHSHRIRAMFINSOUTHBANKSURYODAYTOP15IETFUJJIVANSFBUTKARSHBNKCapital GoodsFinancial Services